| | | | | | | |
 | GILEAD SCIENCES, INC. | -0.21% | 0.91% | -14.28% | -9.18% | -5.38% | 78 068 |
| REGENERON PHARMACEUTICALS, INC. | 1.47% | 9.21% | 3.72% | 26.79% | 112.64% | 70 575 |
| VERTEX PHARMACEUTICALS | 3.02% | 8.15% | 15.74% | 17.08% | 49.31% | 65 005 |
 | WUXI APPTEC CO., LTD. | -2.06% | 1.36% | -16.67% | -22.60% | 185.26% | 42 275 |
| BIONTECH SE | -4.81% | 7.75% | -41.35% | -21.56% | --.--% | 36 745 |
 | GENMAB A/S | 0.33% | 0.96% | -19.54% | -10.19% | 83.36% | 19 313 |
 | ARGENX SE | 0.33% | 8.00% | -4.60% | 32.98% | 159.98% | 17 040 |
| BEIGENE, LTD. | -2.78% | -3.76% | -52.32% | -59.58% | -6.55% | 13 328 |
| NEUROCRINE BIOSCIENCES, INC. | 0.90% | 11.99% | -0.34% | -10.27% | 6.10% | 8 113 |
| EXELIXIS, INC. | 0.90% | 4.76% | 10.83% | -20.74% | 2.37% | 6 498 |
| LEGEND BIOTECH CORPORATION | 3.23% | 21.14% | -12.83% | 37.26% | --.--% | 6 266 |
| SAREPTA THERAPEUTICS, INC. | 2.36% | 3.64% | -25.01% | -11.20% | -44.93% | 5 909 |
| HALOZYME THERAPEUTICS, INC. | 3.14% | 3.01% | 3.68% | -3.11% | 161.87% | 5 744 |
| INTRA-CELLULAR THERAPIES, INC. | -0.30% | 37.02% | 12.57% | 56.70% | 373.63% | 5 558 |
 | BIOCON LIMITED | 3.30% | -5.51% | -9.38% | -14.35% | 26.91% | 4 888 |
| | | | | | | |
| | Gemiddelde | 0.59% | 7.24% | -9.99% | -0.80% | 84.97% | |
| | Gewogen gemiddelde per kap. | 0.19% | 5.65% | -8.62% | 0.74% | 75.23% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
